Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MatsukiyoCocokaraMSMKF 84 EV-to-EBITDA is 7.26 as of Jul. 28, 2026, which is 34% below its 10-year median of 11.04. GuruFocus rates MSMKF with a GF Score™ of 84/100 and a GF Value™ of $20.80 (Modestly Undervalued). Among 509 Healthcare Providers & Services companies, MatsukiyoCocokara ranks better than 67.19% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MatsukiyoCocokara's enterprise value is $5,328 Mil.
MatsukiyoCocokara's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $734 Mil. Therefore, MatsukiyoCocokara's EV-to-EBITDA for today is 7.26.
The historical rank and industry rank for MatsukiyoCocokara's EV-to-EBITDA or its related term are showing as below:
MSMKF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.02 Med: 11.04 Max: 16.69
Current: 7.62
During the past 13 years, the highest EV-to-EBITDA of MatsukiyoCocokara was 16.69. The lowest was 7.02. And the median was 11.04.
MSMKF's EV-to-EBITDA is ranked better than 67.19% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.03
vs MSMKF: 7.62
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
MatsukiyoCocokara's PE Ratio (TTM) for today is calculated as:
MatsukiyoCocokara's share price for today is $14.88.
MatsukiyoCocokara's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.922.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for MatsukiyoCocokara's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, MatsukiyoCocokara's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MatsukiyoCocokara EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MatsukiyoCocokara's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where MatsukiyoCocokara's EV-to-EBITDA falls into.
MatsukiyoCocokara's current Enterprise Value is $5,328 Mil.
MatsukiyoCocokara's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $734 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MatsukiyoCocokara (MSMKF) has a EV-to-EBITDA of 7.26 as of Jul. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on MatsukiyoCocokara. This is 34% below median its historical median of 11.04. Over the past decade, MatsukiyoCocokara's EV-to-EBITDA has ranged from 7.02 to 16.69. According to the industry distribution chart, MatsukiyoCocokara ranks #167 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 32.8%.
Is MatsukiyoCocokara's EV-to-EBITDA too high?
MatsukiyoCocokara's current EV-to-EBITDA of 7.26 is 34% below median its 10-year median of 11.04. Over the past 10 years, this metric has ranged from a low of 7.02 to a high of 16.69. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.03. MatsukiyoCocokara's value of 7.26 is 34.2% below this industry median. Based on the distribution chart, MatsukiyoCocokara ranks #167 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MatsukiyoCocokara has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MatsukiyoCocokara's EV-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MatsukiyoCocokara ranks #167 out of 509 companies for EV-to-EBITDA. This puts MatsukiyoCocokara in the upper half of its industry. The industry median EV-to-EBITDA is 11.03. MatsukiyoCocokara's value of 7.26 is 34.2% below this benchmark. Historically, MatsukiyoCocokara's own EV-to-EBITDA has ranged from 7.02 to 16.69 over the past decade. While the company's 10-year median is 11.04 vs. the industry median of 11.03, MatsukiyoCocokara has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.03, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MatsukiyoCocokara's current EV-to-EBITDA of 7.26 is 34.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on MatsukiyoCocokara. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MatsukiyoCocokara's current EV-to-EBITDA is 7.26, which is 34% below median its own 10-year median of 11.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MatsukiyoCocokara stock overvalued right now?
Based on GuruFocus' analysis, MatsukiyoCocokara (MSMKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.80, compared to a current price of $14.88 — trading 28.5% below its estimated fair value. The current EV-to-EBITDA is 7.26, which is 34% below median its 10-year median of 11.04 and 34.2% below the Healthcare Providers & Services industry median of 11.03. MatsukiyoCocokara's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For MatsukiyoCocokara (MSMKF), the current EV-to-EBITDA is 7.26 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MatsukiyoCocokara (MSMKF) Overvalued in 2026?
Based on GuruFocus' analysis, MatsukiyoCocokara stock appears to be undervalued.
The current stock price of $14.88 is trading 28.5% below its estimated GF Value™ of $20.80.
GuruFocus considers MatsukiyoCocokara to be Modestly Undervalued.
Key valuation signals for MSMKF:
EV-to-EBITDA: 7.26 (34% below median its 10-year median of 11.04)
GF Value™: $20.80 vs. price of $14.88 (28.5% below fair value)
Industry Position: 34.2% below the Healthcare Providers & Services median (#167 of 509)
No single metric tells the full story. See the MSMKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MatsukiyoCocokara & Co operates retail drugstores and insurance dispensing pharmacies in Japan. The company's main segments are the Matsumotokiyoshi Group Business, focused on stores under the Matsumotokiyoshi brand; the Cocokara Fine Group Business, centered on Cocokara Fine stores; and the Management Support Business, which procures products, oversees group operations, and manages indirect functions such as advertising and promotion. It generates the majority of its revenue from the Matsumotokiyoshi Group Business segment.
84GF Score
Get the complete analysis for MSMKF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSMKF has been successfully added to your 
